H, C., C, W., H, D., & J, S. (2026). The METTL3/IGF2BP1 axis-mediated m6 A modification of TRIM11 mRNA suppresses ferroptosis and accelerates malignant progression in non-small cell lung cancer cells by degrading ACSL4. Naunyn-Schmiedeberg's archives of pharmacology, 399(1), 665. https://doi.org/10.1007/s00210-025-04207-7
Chicago Style (17th ed.) CitationH, Chen, Wang C, Dai H, and Shi J. "The METTL3/IGF2BP1 Axis-mediated M6 A Modification of TRIM11 MRNA Suppresses Ferroptosis and Accelerates Malignant Progression in Non-small Cell Lung Cancer Cells by Degrading ACSL4." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 1 (2026): 665. https://doi.org/10.1007/s00210-025-04207-7.
MLA (9th ed.) CitationH, Chen, et al. "The METTL3/IGF2BP1 Axis-mediated M6 A Modification of TRIM11 MRNA Suppresses Ferroptosis and Accelerates Malignant Progression in Non-small Cell Lung Cancer Cells by Degrading ACSL4." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 1, 2026, p. 665, https://doi.org/10.1007/s00210-025-04207-7.